| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | I-SMAD binding | 4.04e-05 | 17 | 80 | 3 | GO:0070411 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 2.87e-06 | 8 | 79 | 3 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 6.12e-06 | 10 | 79 | 3 | GO:0071141 | |
| GeneOntologyCellularComponent | condensin complex | 3.89e-04 | 8 | 79 | 2 | GO:0000796 | |
| Domain | Dwarfin | 3.57e-06 | 8 | 76 | 3 | IPR013790 | |
| Domain | DWB | 3.57e-06 | 8 | 76 | 3 | SM00524 | |
| Domain | MH2 | 3.57e-06 | 8 | 76 | 3 | PS51076 | |
| Domain | MH1 | 3.57e-06 | 8 | 76 | 3 | PS51075 | |
| Domain | - | 3.57e-06 | 8 | 76 | 3 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 3.57e-06 | 8 | 76 | 3 | IPR013019 | |
| Domain | MH2 | 3.57e-06 | 8 | 76 | 3 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 3.57e-06 | 8 | 76 | 3 | IPR001132 | |
| Domain | MAD_homology1_Dwarfin-type | 1.39e-05 | 12 | 76 | 3 | IPR003619 | |
| Domain | DWA | 1.39e-05 | 12 | 76 | 3 | SM00523 | |
| Domain | MH1 | 1.39e-05 | 12 | 76 | 3 | PF03165 | |
| Domain | SMAD_dom-like | 3.49e-05 | 16 | 76 | 3 | IPR017855 | |
| Domain | - | 3.49e-05 | 16 | 76 | 3 | 2.60.200.10 | |
| Domain | SMAD_FHA_domain | 1.24e-03 | 52 | 76 | 3 | IPR008984 | |
| Domain | MAM_1 | 1.89e-03 | 16 | 76 | 2 | PS00740 | |
| Domain | MAM | 2.14e-03 | 17 | 76 | 2 | SM00137 | |
| Domain | MAM | 2.40e-03 | 18 | 76 | 2 | PF00629 | |
| Domain | MAM_dom | 2.40e-03 | 18 | 76 | 2 | IPR000998 | |
| Domain | MAM_2 | 2.40e-03 | 18 | 76 | 2 | PS50060 | |
| Domain | - | 3.58e-03 | 22 | 76 | 2 | 1.10.196.10 | |
| Domain | RGS_subdom1 | 3.58e-03 | 22 | 76 | 2 | IPR024066 | |
| Domain | fn3 | 4.31e-03 | 162 | 76 | 4 | PF00041 | |
| Domain | FN3 | 6.87e-03 | 185 | 76 | 4 | SM00060 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 2.29e-06 | 7 | 58 | 3 | M47845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 3.65e-06 | 8 | 58 | 3 | M47847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 5.46e-06 | 9 | 58 | 3 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 5.46e-06 | 9 | 58 | 3 | M47822 | |
| Pathway | PID_ALK2_PATHWAY | 1.07e-05 | 11 | 58 | 3 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 1.07e-05 | 11 | 58 | 3 | M47848 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 1.84e-05 | 13 | 58 | 3 | M39378 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 7.17e-05 | 20 | 58 | 3 | M47843 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 1.43e-04 | 25 | 58 | 3 | M39665 | |
| Pathway | PID_ALK1_PATHWAY | 1.61e-04 | 26 | 58 | 3 | M185 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 2.27e-04 | 73 | 58 | 4 | MM15285 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 2.74e-04 | 31 | 58 | 3 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 2.74e-04 | 31 | 58 | 3 | MM14789 | |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 4.58e-04 | 8 | 58 | 2 | MM14895 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 4.65e-04 | 37 | 58 | 3 | M39506 | |
| Pathway | PID_AURORA_B_PATHWAY | 5.44e-04 | 39 | 58 | 3 | M14 | |
| Pathway | PID_BMP_PATHWAY | 6.77e-04 | 42 | 58 | 3 | M181 | |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 8.93e-04 | 11 | 58 | 2 | M27182 | |
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 1.17e-08 | 3 | 80 | 3 | 30953749 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 21381028 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 24023003 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 27848974 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 31127639 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 22897816 | ||
| Pubmed | A crucial role of a high mobility group protein HMGA2 in cardiogenesis. | 4.68e-08 | 4 | 80 | 3 | 18425117 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 23993924 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 17967875 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 22452883 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 25536014 | ||
| Pubmed | Characterization of new bone morphogenetic protein (Bmp)-2 regulatory alleles. | 4.68e-08 | 4 | 80 | 3 | 28401685 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 19244313 | ||
| Pubmed | Signal transduction of bone morphogenetic protein receptors. | 4.68e-08 | 4 | 80 | 3 | 14687659 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 25755279 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 34719843 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 27188281 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 38703029 | ||
| Pubmed | Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. | 1.17e-07 | 5 | 80 | 3 | 11121043 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 20651281 | ||
| Pubmed | Grainyhead-like 2 interacts with noggin to regulate tissue fusion in mouse. | 1.17e-07 | 5 | 80 | 3 | 38300806 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 25141865 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 29253505 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 27612439 | ||
| Pubmed | Histone methyltransferase Setdb1 is indispensable for Meckel's cartilage development. | 1.17e-07 | 5 | 80 | 3 | 27890611 | |
| Pubmed | The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. | 1.17e-07 | 5 | 80 | 3 | 21246655 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 18775991 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 26735394 | ||
| Pubmed | FGF-2 enhances Runx-2/Smads nuclear localization in BMP-2 canonical signaling in osteoblasts. | 1.17e-07 | 5 | 80 | 3 | 23559326 | |
| Pubmed | Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon. | 1.17e-07 | 5 | 80 | 3 | 15743817 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 19918795 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 38175868 | ||
| Pubmed | Smad8B, a Smad8 splice variant lacking the SSXS site that inhibits Smad8-mediated signalling. | 1.17e-07 | 5 | 80 | 3 | 10583507 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 33393086 | ||
| Pubmed | Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. | 1.17e-07 | 5 | 80 | 3 | 16813523 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 18395706 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TXLNA TRMT10C ZC3H11A UBE2O GNL3L VPS13C DDX52 UGGT1 ETFB EIF2S2 EHMT1 GIGYF2 CHD1 SMC2 NCAPH SDAD1 | 1.31e-07 | 1425 | 80 | 16 | 30948266 |
| Pubmed | 1.51e-07 | 21 | 80 | 4 | 36941249 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 2.33e-07 | 6 | 80 | 3 | 18952608 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 25470749 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 20837004 | ||
| Pubmed | Lack of the bone morphogenetic protein BMP6 induces massive iron overload. | 2.33e-07 | 6 | 80 | 3 | 19252488 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 28576771 | ||
| Pubmed | Development of bat flight: morphologic and molecular evolution of bat wing digits. | 2.33e-07 | 6 | 80 | 3 | 16618938 | |
| Pubmed | Mesenchymal bone morphogenetic protein signaling is required for normal pancreas development. | 2.33e-07 | 6 | 80 | 3 | 20522595 | |
| Pubmed | Quantitative analysis of signaling responses during mouse primordial germ cell specification. | 2.33e-07 | 6 | 80 | 3 | 34184730 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 21518886 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 27250101 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 20042635 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 33436697 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 11850197 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 15188429 | ||
| Pubmed | BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells. | 2.33e-07 | 6 | 80 | 3 | 19269967 | |
| Pubmed | SMAD expression in the testis: an insight into BMP regulation of spermatogenesis. | 2.33e-07 | 6 | 80 | 3 | 18069690 | |
| Pubmed | The dorsal aorta initiates a molecular cascade that instructs sympatho-adrenal specification. | 2.33e-07 | 6 | 80 | 3 | 22723422 | |
| Pubmed | BMPER-induced BMP signaling promotes coronary artery remodeling. | 4.07e-07 | 7 | 80 | 3 | 24373957 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 15009097 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 20807528 | ||
| Pubmed | Emergence of dorsal-ventral polarity in ESC-derived retinal tissue. | 4.07e-07 | 7 | 80 | 3 | 27633992 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 19782070 | ||
| Pubmed | Noggin is required for early development of murine upper incisors. | 4.07e-07 | 7 | 80 | 3 | 22302143 | |
| Pubmed | Precise spatial restriction of BMP signaling is essential for articular cartilage differentiation. | 4.07e-07 | 7 | 80 | 3 | 25758226 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 23680673 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 19116164 | ||
| Pubmed | Cnn3 regulates neural tube morphogenesis and neuronal stem cell properties. | 4.07e-07 | 7 | 80 | 3 | 29151265 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 16624858 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 24269886 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 15376321 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 18322278 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 18003744 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 4.07e-07 | 7 | 80 | 3 | 11163184 | |
| Pubmed | Role of smad- and wnt-dependent pathways in embryonic cardiac development. | 4.07e-07 | 7 | 80 | 3 | 16522160 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZC3H11A KMT2D CCDC59 HDAC6 INTS12 DDX52 EIF2S2 SIM2 SMC2 NCAPH TTF1 SMAD9 | 6.02e-07 | 857 | 80 | 12 | 25609649 |
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 6.51e-07 | 8 | 80 | 3 | 19211612 | |
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 10647776 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 29126155 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 29135976 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 28574994 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 23804438 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 17301089 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 23064761 | ||
| Pubmed | Bmp signaling is required for development of primary lens fiber cells. | 6.51e-07 | 8 | 80 | 3 | 12117821 | |
| Pubmed | Bmp7 functions via a polarity mechanism to promote cloacal septation. | 6.51e-07 | 8 | 80 | 3 | 22253716 | |
| Pubmed | SETDB1 is essential for mouse primordial germ cell fate determination by ensuring BMP signaling. | 6.51e-07 | 8 | 80 | 3 | 30446626 | |
| Pubmed | Enhanced BMP signaling through ALK2 attenuates keratinocyte differentiation. | 6.51e-07 | 8 | 80 | 3 | 36116371 | |
| Pubmed | A molecular roadmap of the AGM region reveals BMPER as a novel regulator of HSC maturation. | 6.51e-07 | 8 | 80 | 3 | 29093060 | |
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 10708949 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 25896202 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 23458899 | ||
| Pubmed | UBE2O GNL3L KIN CCDC174 VPS13C UGGT1 EIF2S2 OSBPL8 CHD1 PCDH17 TGS1 | 9.47e-07 | 733 | 80 | 11 | 34672954 | |
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 19018011 | ||
| Pubmed | BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development. | 9.75e-07 | 9 | 80 | 3 | 28641928 | |
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 37272529 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 9.75e-07 | 9 | 80 | 3 | 24932701 | |
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 30735122 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 17522159 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 9759503 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 25514040 | ||
| Pubmed | Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. | 9.75e-07 | 9 | 80 | 3 | 16765933 | |
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 30134160 | ||
| Interaction | SERF2 interactions | 2.34e-05 | 87 | 79 | 5 | int:SERF2 | |
| Interaction | SNRNP70 interactions | TRMT10C ZC3H11A UBE2O CCDC59 KIN DDX52 EIF2S2 CDKL3 CDC14B SDAD1 SMAD1 SMAD5 SMAD9 TGS1 | 2.55e-05 | 984 | 79 | 14 | int:SNRNP70 |
| Interaction | TOB1 interactions | 2.64e-05 | 44 | 79 | 4 | int:TOB1 | |
| GeneFamily | SMAD family | 9.14e-07 | 8 | 47 | 3 | 750 | |
| GeneFamily | Fibronectin type III domain containing | 7.83e-04 | 160 | 47 | 4 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.24e-03 | 181 | 47 | 4 | 694 | |
| GeneFamily | Regulators of G-protein signaling | 1.35e-03 | 21 | 47 | 2 | 720 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.91e-03 | 25 | 47 | 2 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.52e-03 | 34 | 47 | 2 | 487 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.44e-03 | 161 | 47 | 3 | 593 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | 7.78e-06 | 445 | 79 | 9 | MM3853 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.07e-06 | 186 | 77 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | EVI5 TRMT10C UBE2O INTS12 KIN GCC2 EIF2S2 CHD1 SMC2 NCAPH CDC14B PCDH17 SMAD5 SMAD9 TGS1 | 3.70e-05 | 1252 | 77 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.70e-09 | 198 | 80 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 7.45e-08 | 200 | 80 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.11e-06 | 187 | 80 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 193 | 80 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 193 | 80 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 194 | 80 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-05 | 177 | 80 | 5 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.09e-05 | 185 | 80 | 5 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.14e-05 | 186 | 80 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 188 | 80 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 190 | 80 | 5 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.37e-05 | 190 | 80 | 5 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.37e-05 | 190 | 80 | 5 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 193 | 80 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-05 | 193 | 80 | 5 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 2.55e-05 | 193 | 80 | 5 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 193 | 80 | 5 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.55e-05 | 193 | 80 | 5 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 2.75e-05 | 196 | 80 | 5 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Large_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 197 | 80 | 5 | 7e0834b3947031bf244a10624dcf3f2095c79368 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 198 | 80 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 2.96e-05 | 199 | 80 | 5 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.96e-05 | 199 | 80 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.96e-05 | 199 | 80 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.96e-05 | 199 | 80 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.03e-05 | 200 | 80 | 5 | 98f6a86fbbe5305c71dae91e7278de9813827935 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Macrophages|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.03e-05 | 200 | 80 | 5 | d7b89a721988660d8010c804916f5d0ef2520ee2 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.03e-05 | 200 | 80 | 5 | 1ed1c673184f0c6aae04f90edbb1383b1c1f64d9 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.03e-05 | 200 | 80 | 5 | 2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.42e-05 | 132 | 80 | 4 | c6bf0b4b9e33b517629faf4559a21d7ba720ee6a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-04 | 151 | 80 | 4 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 158 | 80 | 4 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 163 | 80 | 4 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 80 | 4 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 80 | 4 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.49e-04 | 170 | 80 | 4 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 172 | 80 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.60e-04 | 172 | 80 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | mild-Others-CD34+_GATA2+_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.60e-04 | 172 | 80 | 4 | 379f6f271e653d5e404851e51a189bd582bb0f43 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 172 | 80 | 4 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-04 | 173 | 80 | 4 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 173 | 80 | 4 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 175 | 80 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 175 | 80 | 4 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 175 | 80 | 4 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 176 | 80 | 4 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.90e-04 | 177 | 80 | 4 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 177 | 80 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 177 | 80 | 4 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-04 | 177 | 80 | 4 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 177 | 80 | 4 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 178 | 80 | 4 | 462111b61f37338f97ac7dc6c7da1d4316b54445 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.03e-04 | 179 | 80 | 4 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.09e-04 | 180 | 80 | 4 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.09e-04 | 180 | 80 | 4 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.09e-04 | 180 | 80 | 4 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 181 | 80 | 4 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.16e-04 | 181 | 80 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 181 | 80 | 4 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 3.16e-04 | 181 | 80 | 4 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 182 | 80 | 4 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 3.22e-04 | 182 | 80 | 4 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-04 | 182 | 80 | 4 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 182 | 80 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.29e-04 | 183 | 80 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.29e-04 | 183 | 80 | 4 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 3.36e-04 | 184 | 80 | 4 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 3.36e-04 | 184 | 80 | 4 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 184 | 80 | 4 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 3.36e-04 | 184 | 80 | 4 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-04 | 185 | 80 | 4 | 282b3de8850f3c21704339e8d8737b432a43441a | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.43e-04 | 185 | 80 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.43e-04 | 185 | 80 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 186 | 80 | 4 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 186 | 80 | 4 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 187 | 80 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-04 | 187 | 80 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.64e-04 | 188 | 80 | 4 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-04 | 188 | 80 | 4 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.64e-04 | 188 | 80 | 4 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-04 | 188 | 80 | 4 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-04 | 188 | 80 | 4 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-04 | 188 | 80 | 4 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 188 | 80 | 4 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 3.64e-04 | 188 | 80 | 4 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 188 | 80 | 4 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-04 | 188 | 80 | 4 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.64e-04 | 188 | 80 | 4 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-04 | 189 | 80 | 4 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.72e-04 | 189 | 80 | 4 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| Drug | 5-methoxypsoralen | 1.45e-06 | 7 | 80 | 3 | ctd:C022909 | |
| Drug | LDN 193189 | 2.31e-06 | 8 | 80 | 3 | ctd:C554430 | |
| Drug | 1,3,2-dioxaborolan-2-ol | 3.31e-05 | 104 | 80 | 5 | CID005289333 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A | 5.30e-05 | 188 | 80 | 6 | 3046_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.46e-05 | 189 | 80 | 6 | 4304_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 5.62e-05 | 190 | 80 | 6 | 4307_DN | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 5.78e-05 | 191 | 80 | 6 | 2840_UP | |
| Drug | imperatorin | 6.13e-05 | 22 | 80 | 3 | ctd:C031534 | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 7327_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2741_UP | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 1346_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 3708_DN | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 5410_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 3576_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 4159_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; HL60; HT_HG-U133A | 7.46e-05 | 200 | 80 | 6 | 2988_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; HL60; HT_HG-U133A | 7.46e-05 | 200 | 80 | 6 | 2573_UP | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 4.61e-06 | 13 | 76 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | monocyte percentage of leukocytes | 1.08e-04 | 731 | 76 | 9 | EFO_0007989 | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 1.36e-04 | 7 | 76 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | Idiopathic pulmonary hypertension | 2.33e-04 | 9 | 76 | 2 | C0152171 | |
| Disease | mean platelet volume | 2.82e-04 | 1020 | 76 | 10 | EFO_0004584 | |
| Disease | cognitive function measurement | ZNF385D KMT2D ERCC4 KALRN SETBP1 CDKL3 GIGYF2 SMC2 CDC14B RGS3 PCDH17 MYBPC2 | 2.87e-04 | 1434 | 76 | 12 | EFO_0008354 |
| Disease | neutrophil percentage of granulocytes | 3.12e-04 | 228 | 76 | 5 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 3.51e-04 | 234 | 76 | 5 | EFO_0007996 | |
| Disease | bitter alcoholic beverage consumption measurement | 3.94e-04 | 133 | 76 | 4 | EFO_0010092 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 5.84e-04 | 14 | 76 | 2 | C1150929 | |
| Disease | Idiopathic pulmonary arterial hypertension | 7.67e-04 | 16 | 76 | 2 | C3203102 | |
| Disease | Rolandic epilepsy | 7.67e-04 | 16 | 76 | 2 | Orphanet_1945 | |
| Disease | Familial primary pulmonary hypertension | 8.68e-04 | 17 | 76 | 2 | C0340543 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.04e-03 | 26 | 76 | 2 | EFO_0008007, EFO_0021497 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEKLEKMMEKKGTKI | 836 | Q15361 | |
| KKLKALEAMKNKQKS | 106 | Q9H6B1 | |
| KQKKKMIKKPLERES | 551 | Q9Y2R4 | |
| SVVKMEANQKAKKKK | 1691 | Q9P281 | |
| KRKKKKMPEILKTEL | 216 | Q96FF9 | |
| HKNSMKKKAKIKNVT | 286 | Q8IUX8 | |
| KKLKSITMLRKKIVH | 106 | O60729 | |
| VKQIKMLKRESKKTE | 541 | Q8IVW4 | |
| EKLDKKLKKMEQNKT | 276 | P18848 | |
| KEAKVKKLVVKVHMN | 171 | Q7Z5R6 | |
| KKKVIMKKRKKLTLT | 71 | Q96SM3 | |
| KKLKSITMLRKKIVH | 76 | A4D256 | |
| AKKNKAMKSIKVKEE | 1336 | O14646 | |
| KGKKKKINKNDIMLV | 756 | O14917 | |
| KVAVRKQRKKIKAKM | 291 | Q96NA2 | |
| KRKSKNLAKDMKNKL | 1021 | P49796 | |
| KRLQMVKKKAAQKKL | 446 | Q96CB8 | |
| SKEKKKKKSALDEIM | 251 | O60870 | |
| IKEKMKTVKHKILVL | 46 | P53384 | |
| MKKLKEVTDKKKTNL | 171 | A8MVJ9 | |
| QMKKVVKTVAVKILK | 391 | P43405 | |
| KDMLEKKVKKVVVSN | 261 | Q58FG0 | |
| KKMKKLEKEYTTIKT | 406 | O60447 | |
| AVKFVSKKMKKKEQA | 2711 | O60229 | |
| TKEKNKKVMFLPKKA | 806 | Q86VP3 | |
| PAVIVDKKMQKKMKK | 101 | Q9NZ81 | |
| KKKKTIKMLMLVVVL | 286 | Q9NYM4 | |
| DLDIMLGNKKKKKKN | 116 | P20042 | |
| KMKHKPTRQQKKVAK | 781 | Q9BZF1 | |
| KSLDKQKKKTKMTDE | 216 | Q13177 | |
| NEASKIMKKKKKVLV | 126 | Q569G3 | |
| EAVQSGKKKKKQKMV | 1256 | Q6Y7W6 | |
| KKEKGKKLSRMKLLL | 66 | P30968 | |
| EKQKLKKKLKEGMLS | 1041 | P01031 | |
| KINKIKLVAVKAKKE | 966 | Q8IWJ2 | |
| KKVLKKMLKFLAKGE | 91 | O95260 | |
| KMKKKIIKDQKLLVI | 586 | O75899 | |
| LAKLRQKKMKKSKEG | 296 | Q6PII3 | |
| NLAEVKKKGKMKKLG | 46 | Q9UBN7 | |
| EFKAKNIKKKKVSIM | 61 | O75052 | |
| KVLKSKMKKRVVSIV | 376 | Q99680 | |
| KERADKKILKVMKKN | 1671 | Q9P225 | |
| KKKTKVLKQRTVIEM | 301 | Q9H9B1 | |
| SLRNKEVKKAVKKML | 321 | Q8NGG3 | |
| VLVMKKRKLAKKRKE | 761 | P28827 | |
| KARKIEKKGTMKKQA | 116 | Q92541 | |
| KIHLMQNGKRLKKKK | 311 | Q8N9I0 | |
| TRKDLMDKTQKVKVK | 221 | Q9Y3A2 | |
| GKLKKKKMAKRIQQV | 111 | Q05952 | |
| LKALEAQKMMKKKKE | 226 | Q9C093 | |
| KKIKSPAKMAEKAKQ | 101 | O15539 | |
| GVMLFKKKKTRKLKI | 331 | Q86YW0 | |
| KSTMKKELEAAQKKK | 321 | Q8IVM8 | |
| KNKKKMQKRADKIAS | 546 | Q9NVN8 | |
| PNIMKAKKKKIEVIK | 196 | P38117 | |
| TRKLVKPKNTKMKTK | 366 | Q14190 | |
| KKKMEVFKILNKKTK | 206 | Q9P031 | |
| SSKNKKKLEKAMKVL | 256 | Q9NVU7 | |
| LVKKLKKKKGAMDEL | 41 | O15198 | |
| DALVKKLKKKKGAME | 36 | Q99717 | |
| ALVKKLKKKKGAMEE | 36 | Q15797 | |
| KGQKAANLDLKKKMK | 721 | Q8TDI8 | |
| ILSMKEDIKALKKKV | 126 | Q8NEL0 | |
| AKTAKKMDMKKLKQS | 636 | Q15003 | |
| KQKVMVAVKIISKKK | 46 | Q6SA08 | |
| TLEEIKSKKMKEKSK | 216 | O75152 | |
| SMAKKVKRLLKKQVV | 381 | Q9C0C9 | |
| IKEVVVTLMKKSEKK | 1431 | Q709C8 | |
| LMKKKRIVENDKSKI | 1001 | O95347 | |
| LAKKKVMAPSKIKVK | 586 | Q9NPG3 | |
| KKKKRKLTLTQMVGK | 486 | Q92889 | |
| MNTRNKVKIKKKKHQ | 116 | Q96RS0 | |
| AVKIKETKVMKLRKL | 301 | Q9UJV3 | |
| KLSSKVMTKVIKKKI | 801 | O15050 | |
| GVLDKKTIKTINKMK | 656 | Q9Y6X0 | |
| KTIKTINKMKTLKRK | 661 | Q9Y6X0 | |
| KVKKARQIKKEMKAA | 141 | Q7L0Y3 | |
| KSKIIKVKVQKKADM | 1201 | Q9NYU2 | |
| FKQEMEKMTKKIKKL | 411 | P40222 | |
| EKMTKKIKKLEKETT | 416 | P40222 | |
| KAKMVALKGIKKVMA | 3426 | O14686 | |
| MLKRLKKAKVEVKKS | 241 | Q14324 | |
| VKKKLKEMKMSLEKA | 1041 | Q9ULJ8 |